Harnessing hypoxic adaptation to prevent, treat, and repair stroke Review uri icon


MeSH Major

  • Brain
  • Enzyme Inhibitors
  • Hypoxia, Brain
  • Neuroprotective Agents
  • Oxygen
  • Stroke


  • The brain demands oxygen and glucose to fulfill its roles as the master regulator of body functions as diverse as bladder control and creative thinking. Chemical and electrical transmission in the nervous system is rapidly disrupted in stroke as a result of hypoxia and hypoglycemia. Despite being highly evolved in its architecture, the human brain appears to utilize phylogenetically conserved homeostatic strategies to combat hypoxia and ischemia. Specifically, several converging lines of inquiry have demonstrated that the transcription factor hypoxia-inducible factor-1 (HIF1-1) mediates the activation of a large cassette of genes involved in adaptation to hypoxia in surviving neurons after stroke. Accordingly, pharmacological or molecular approaches that engage hypoxic adaptation at the point of one of its sensors (e.g., inhibition of HIF prolyl 4 hydroxylases) leads to profound sparing of brain tissue and enhanced recovery of function. In this review, we discuss the potential mechanisms that could subserve protective and restorative effects of augmenting hypoxic adaptation in the brain. The strategy appears to involve HIF-dependent and HIF-independent pathways and more than 70 genes and proteins activated transcriptionally and post-transcriptionally that can act at cellular, local, and system levels to compensate for oxygen insufficiency. The breadth and depth of this homeostatic program offers a hopeful alternative to the current pessimism towards stroke therapeutics.

publication date

  • December 2007



  • Review



  • eng

PubMed Central ID

  • PMC2121656

Digital Object Identifier (DOI)

  • 10.1007/s00109-007-0283-1

PubMed ID

  • 18043901

Additional Document Info

start page

  • 1331

end page

  • 8


  • 85


  • 12